This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmad, N., H. J. Gabius, et al. (2004). “Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes.” J Biol Chem 279(12): 10841–7.
Barboni, E. A., S. Bawumia, et al. (1999). “Kinetic measurements of binding of galectin 3 to a laminin substratum.” Glycoconj J 16(7): 365–73.
Bigge, J. C., T. P. Patel, et al. (1995). “Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid.” Anal Biochem 230(2): 229–38.
Dalziel, M., C. Whitehouse, et al. (2001). “The relative activities of the C2GnT1 and ST3Gal-I glycosyl-transferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.” J Biol Chem 276(14): 11007–15.
Dennis, J. W., S. Laferte, et al. (1987). “Beta 1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis.” Science 236(4801): 582–5.
Egeblad, M. and Z. Werb (2002). “New functions for the matrix metalloproteinases in cancer progression.” Nat Rev Cancer 2(3): 161–74.
Feizi, T. (1985). “Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens.” Nature 314(6006): 53–7.
Fernandes, B., U. Sagman, et al. (1991). “Beta 1–6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia.” Cancer Res 51(2): 718–23.
Fosang, A. J., P. J. Neame, et al. (1992). “The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.” J Biol Chem 267(27): 19470–4.
Granovsky, M., J. Fata, et al. (2000). “Suppression of tumor growth and metastasis in Mgat5-deficient mice.” Nat Med 6(3): 306–12.
Hibbs, M. S., J. R. Hoidal, et al. (1987). “Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.” J Clin Invest 80(6):1644–50.
Hirabayashi, J., T. Hashidate, et al. (2002). “Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.” Biochim Biophys Acta 1572(2–3): 232–54.
Honjo, Y., P. Nangia-Makker, et al. (2001). “Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.” Clin Cancer Res 7(3): 661–8.
Houde, M., G. de Bruyne, et al. (1993). “Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells.” Int J Cancer 53(3): 395–400.
Hua, J. and R. J. Muschel (1996). “Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.” Cancer Res 56(22): 5279–84.
Ihara, S., E. Miyoshi, et al. (2002). “Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1–6 GlcNAc branching.” J Biol Chem 277(19): 16960–7.
Itoh, T., M. Tanioka, et al. (1999). “Experimental metastasis is suppressed in MMP-9-deficient mice.” Clin Exp Metastasis 17(2): 177–81.
Kim, Y. J. and A. Varki (1997). “Perspectives on the significance of altered glycosylation of glycoproteins in cancer.” Glycoconj J 14(5): 569–76.
Kotra, L. P., L. Zhang, et al. (2002). “N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9.” Bioorg Chem 30(5): 356–70.
Lloyd, K. O., J. Burchell, et al. (1996). “Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.” J Biol Chem 271(52): 33325–34.
Lukacik, P., P. Roversi, et al. (2004). “Complement regulation at the molecular level: the structure of decay-accelerating factor.” Proc Natl Acad Sci U S A 101(5): 1279–84.
Mackay, A. R., J. L. Hartzler, et al. (1990). “Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.” J Biol Chem 265(35): 21929–34.
Masure, S., P. Proost, et al. (1991). “Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8.” Eur J Biochem 198(2): 391–8.
Matarrese, P., O. Fusco, et al. (2000). “Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.” Int J Cancer 85(4): 545–54.
Mattu, T. S., L. Royle, et al. (2000). “O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme.” Biochemistry 39(51): 15695–704.
Murphy, G. and A. J. Docherty (1992). “The matrix metalloproteinases and their inhibitors.” Am J Respir CellMol Biol 7(2): 120–5.
Murphy, G., A. Houbrechts, et al. (1991). “The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.” Biochemistry 30(33): 8097–102.
Nagase, H. and J. F. Woessner, Jr. (1999). “Matrix metalloproteinases.” J Biol Chem 274(31): 21491–4.
Nguyen, Q., G. Murphy, et al. (1993). “Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein.” Biochem J 295 (Pt 2): 595–8.
Ochieng, J., R. Fridman, et al. (1994). “Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9.” Biochemistry 33(47): 14109–14.
Ochieng, J., M. L. Leite-Browning, et al. (1998). “Regulation of cellular adhesion to extracellular matrix proteins by galectin-3.” Biochem Biophys Res Commun 246(3): 788–91.
Ochieng, J., D. Platt, et al. (1993). “Structure-function relationship of a recombinant human galactoside-binding protein.” Biochemistry 32(16): 4455–60.
Okada, Y., Y. Gonoji, et al. (1992). “Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.” J Biol Chem 267(30): 21712–9.
Opdenakker, G., S. Masure, et al. (1991). “Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.” Lymphokine Cytokine Res 10(4): 317–24.
Opdenakker, G., P. E. Van den Steen, et al. (2001). “Gelatinase B: a tuner and amplifier of immune functions.” Trends Immunol 22(10): 571–9.
Royle, L., T. S. Mattu, et al. (2002). “An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins.” Anal Biochem 304(1): 70–90.
Rudd, P. M., T. S. Mattu, et al. (1999). “Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.” Biochemistry 38(42): 13937–50.
Rudd, P. M., R. J. Woods, et al. (1995). “The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator.” Biochim Biophys Acta 1248(1): 1–10.
Saitoh, O., W. C. Wang, et al. (1992). “Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials.” J Biol Chem 267(8): 5700–11.
Seetharaman, J., A. Kanigsberg, et al. (1998). “X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.” J Biol Chem 273(21): 13047–52.
Senior, R. M., G. L. Griffin, et al. (1991). “Human 92-and 72-kilodalton type IV collagenases are elastases.” J Biol Chem 266(12): 7870–5.
Van den Steen, P. E., B. Dubois, et al. (2002). “Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).” Crit Rev Biochem Mol Biol 37(6): 375–536.
Van den Steen, P. E., G. Opdenakker, et al. (2001). “Matrix remodelling enzymes, the protease cascade and glycosylation.” Biochim Biophys Acta 1528(2–3): 61–73.
Van den Steen, P. E., P. Proost, et al. (2004). “Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.” Biochemistry 43(33): 10809–16.
Wilhelm, S. M., I. E. Collier, et al. (1989). “SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.” J Biol Chem 264(29): 17213–21.
Zucker, S., R. M. Lysik, et al. (1993). “M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.” Cancer Res 53(1): 140–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this paper
Cite this paper
Fry, S.A. et al. (2005). Differential Glycosylation of Gelatinase B from Neutrophils and Breast Cancer Cells. In: Axford, J.S. (eds) Glycobiology and Medicine. Advances in Experimental Medicine and Biology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25515-X_18
Download citation
DOI: https://doi.org/10.1007/0-387-25515-X_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25514-9
Online ISBN: 978-0-387-25515-6
eBook Packages: MedicineMedicine (R0)